{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:41Z","timestamp":1792794761082,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clgc.2024.102144","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T06:56:08Z","timestamp":1719039368000},"page":"102144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6730-132X","authenticated-orcid":false,"given":"Abolfazl","family":"Salari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Ghahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3550-2735","authenticated-orcid":false,"given":"Masoud","family":"Bitaraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2472-9942","authenticated-orcid":false,"given":"Elahe Samiee","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Momeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hassan","family":"Inanloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichehr","family":"Ghahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamoud Mohamed","family":"Mohamoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohamadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Nowroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-0047","authenticated-orcid":false,"given":"Erfan","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2024.102144_bib0001","unstructured":"GLOBOCAN. GLOBOCAN 2022: Bladder cancer 9th most common worldwide. 2024."},{"key":"10.1016\/j.clgc.2024.102144_bib0002","doi-asserted-by":"crossref","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. 2023.","DOI":"10.1016\/j.eururo.2023.03.029"},{"issue":"6","key":"10.1016\/j.clgc.2024.102144_bib0003","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ame2.12293","article-title":"Evaluation of direct intramural injection to the bladder wall as a method for developing orthotopic tumor models","volume":"5","author":"Bitaraf","year":"2022","journal-title":"Animal model exp med"},{"key":"10.1016\/j.clgc.2024.102144_bib0004","unstructured":"Guidelines E. muscle-invasive and metastatic bladder cancer. EAU Guidelines Office, Arnhem, The Netherlands http:\/\/www.uroweborg\/guidelines\/compilations-of-all-guidelines\/. (Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.)."},{"issue":"2","key":"10.1016\/j.clgc.2024.102144_bib0005","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.clgc.2021.10.007","article-title":"Association between preoperative De Ritis (AST\/ALT) ratio and oncological outcomes following radical cystectomy in patients with urothelial bladder cancer","volume":"20","author":"Ghahari","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2024.102144_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115015","article-title":"Evaluation of the association of chronic inflammation and cancer: Insights and implications","volume":"164","author":"Nigam","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.clgc.2024.102144_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann African Med"},{"issue":"5","key":"10.1016\/j.clgc.2024.102144_bib0008","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2024.102144_bib0009","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/OTT.S153290","article-title":"therapy. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis","author":"Sacdalan","year":"2018","journal-title":"OncoTargets Ther"},{"issue":"34","key":"10.1016\/j.clgc.2024.102144_bib0010","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","article-title":"Systemic immune-inflammation index for predicting prognosis of colorectal cancer","volume":"23","author":"Chen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clgc.2024.102144_bib0011","first-page":"3145","volume":"10","author":"Song","year":"2017","journal-title":"Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer"},{"key":"10.1016\/j.clgc.2024.102144_bib0012","doi-asserted-by":"crossref","unstructured":"Hu H, Yao X, Xie X, Wu X, Zheng C, Xia W, et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. 2017;35:261-70.","DOI":"10.1007\/s00345-016-1864-9"},{"key":"10.1016\/j.clgc.2024.102144_bib0013","doi-asserted-by":"crossref","unstructured":"Wu S, Zhao X, Wang Y, et al. Pretreatment neutrophil-lymphocyte ratio as a predictor in bladder cancer and metastatic or unresectable urothelial carcinoma patients: a pooled analysis of comparative studies. 2018;46(4):1352-64.","DOI":"10.1159\/000489152"},{"issue":"2","key":"10.1016\/j.clgc.2024.102144_bib0014","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA"},{"issue":"5","key":"10.1016\/j.clgc.2024.102144_bib0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer cell"},{"issue":"1","key":"10.1016\/j.clgc.2024.102144_bib0016","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer cell"},{"issue":"8","key":"10.1016\/j.clgc.2024.102144_bib0017","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1172\/JCI67484","article-title":"Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis","volume":"123","author":"Cools-Lartigue","year":"2013","journal-title":"J Clin Investigation"},{"key":"10.1016\/j.clgc.2024.102144_bib0018","unstructured":"He X-Y, Gao Y, Ng D, et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. 2024."},{"issue":"34","key":"10.1016\/j.clgc.2024.102144_bib0019","doi-asserted-by":"crossref","first-page":"54564","DOI":"10.18632\/oncotarget.10515","article-title":"Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib","volume":"7","author":"Lolli","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clgc.2024.102144_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?","volume":"7","author":"Christine","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2024.102144_bib0021","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.3390\/ijms24065846","article-title":"S SFJIjoms. Blood-based biomarkers as prognostic factors of recurrent disease after radical cystectomy: a systematic review and meta-analysis","volume":"24","author":"Ofner","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clgc.2024.102144_bib0022","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10147-017-1171-5","article-title":"The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis","volume":"22","author":"Tang","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102144_bib0023","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.eururo.2014.02.042","article-title":"Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy","volume":"66","author":"Viers","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102144_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-020-1167-x","article-title":"Xu LJBg. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis","volume":"20","author":"Cao","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clgc.2024.102144_bib0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2018.01.013","article-title":"Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinoma","volume":"479","author":"Yang","year":"2018","journal-title":"Clinica Chimica Acta"},{"issue":"14","key":"10.1016\/j.clgc.2024.102144_bib0026","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1002\/cam4.3135","article-title":"Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti\u2013PD-1 therapy","volume":"9","author":"Dharmapuri","year":"2020","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.clgc.2024.102144_bib0027","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/imt-2020-0105","article-title":"Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy","volume":"12","author":"Kartolo","year":"2020","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.clgc.2024.102144_bib0028","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12885-024-11969-5","article-title":"Inflammatory markers predict survival in patients with postoperative urothelial carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.clgc.2024.102144_bib0029","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1007\/s13277-015-3613-x","article-title":"Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol"},{"issue":"43","key":"10.1016\/j.clgc.2024.102144_bib0030","doi-asserted-by":"crossref","first-page":"75381","DOI":"10.18632\/oncotarget.18856","article-title":"Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.clgc.2024.102144_bib0031","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3390\/cancers15204987","article-title":"Upper tract urothelial carcinoma (UTUC) diagnosis and risk stratification: a comprehensive review","volume":"15","author":"Bitaraf","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2024.102144_bib0032","first-page":"13","article-title":"High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis","author":"Liu","year":"2023","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2024.102144_bib0033","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3390\/medicina59122063","article-title":"Is systemic immune-inflammation index a real non-invasive biomarker to predict oncological outcomes in patients eligible for radical cystectomy?","volume":"59","author":"Russo","year":"2023","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.clgc.2024.102144_bib0034","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/bjc.2012.292","article-title":"A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer","volume":"107","author":"Proctor","year":"2012","journal-title":"British J Cancer"},{"issue":"10","key":"10.1016\/j.clgc.2024.102144_bib0035","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/bjc.2014.180","article-title":"Validation of the pretreatment derived neutrophil\u2013lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma","volume":"110","author":"Dalpiaz","year":"2014","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2024.102144_bib0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/bjc.2014.631","article-title":"The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy","volume":"112","author":"Ku","year":"2015","journal-title":"British J Cancer"},{"issue":"10","key":"10.1016\/j.clgc.2024.102144_bib0037","first-page":"3027","article-title":"Bryniarski PJERfM, Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy","volume":"22","author":"Rajwa","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clgc.2024.102144_bib0038","article-title":"Diagnostic value of inflammatory factors in pathology of bladder cancer patients","volume":"7","author":"Tang","year":"2020","journal-title":"Front Molecul Biosci"},{"issue":"3","key":"10.1016\/j.clgc.2024.102144_bib0039","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/curroncol30030197","article-title":"Predictive value of inflammatory and nutritional indexes in the pathology of bladder cancer patients treated with radical cystectomy","volume":"30","author":"Prijovic","year":"2023","journal-title":"Curr Oncol (Toronto, Ont)"},{"issue":"3","key":"10.1016\/j.clgc.2024.102144_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/BLC-160055","article-title":"Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in patients undergoing pre-operative chemotherapy in muscle-invasive bladder cancer","volume":"2","author":"van Kessel","year":"2016","journal-title":"Bladder Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2024.102144_bib0041","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/23744235.2017.1388537","article-title":"Pitfalls in studies of eosinopenia and neutrophil-to-lymphocyte count ratio","volume":"50","author":"Karakonstantis","year":"2018","journal-title":"Infect Dis"},{"issue":"6","key":"10.1016\/j.clgc.2024.102144_bib0042","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.clgc.2016.04.008","article-title":"The clinical use of the neutrophil to lymphocyte ratio (NLR) in urothelial cancer: a systematic review","volume":"14","author":"Marchioni","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2024.102144_bib0043","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer","author":"Ferro","year":"2022"},{"key":"10.1016\/j.clgc.2024.102144_bib0044","doi-asserted-by":"crossref","unstructured":"Contieri R, Hurle R, Paciotti M, et al. Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG. 2022.","DOI":"10.23736\/S2724-6051.22.04953-9"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:57:07Z","timestamp":1738565827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1558767324001150"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102144","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102144"}}